Literature DB >> 8955174

Regulatory T cells in maintenance and reversal of peripheral tolerance in vivo.

Y Y Kong1, M Eto, K Omoto, M Umesue, A Hashimoto, K Nomoto.   

Abstract

Whether regulatory T cells could suppress the immune responses to an unrelated Ag and could induce tolerance to that Ag was investigated. In female B6 (I-Ab) mice tolerized to MHC class II I-Abm12 (bm12) alloantigen by cyclophosphamide-induced system, regulatory T cells specific for bm12 Ag were induced. These regulatory T cells suppressed in vivo immune responses to an unrelated Ag (male Ag) that was co-expressed with bm12 Ag on the same graft. However, the immune responses to male Ag suppressed by regulatory T cells were reverted by immunization with male Ag alone, indicating regulatory T cells suppressed the induction of immune responses to the unrelated Ag co-expressed with suppressogenic determinant, but did not inactivate T cells specific for that third Ag, such as clonal anergy or deletion. These results provided that minor Ag adjacent to major Ag, even if they were expressed on the professional APC, could be suppressed in the periphery, and the responses to those minor Ag could be activated when the suppression mechanism was abrogated or ineffective.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955174

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice.

Authors:  M Eto; Y Y Kong; J Uozumi; S Naito; K Nomoto
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

Review 2.  Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

Authors:  F Lussana; M Di Ianni; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

Review 3.  Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.

Authors:  Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

4.  Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model.

Authors:  H Uchiyama; Y Kong; K Kishihara; K Sugimachi; K Nomoto
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

Review 5.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

Review 6.  Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors:  Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal:  Nat Rev Clin Oncol       Date:  2015-08-25       Impact factor: 66.675

7.  Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.

Authors:  Lucas P Wachsmuth; Michael T Patterson; Michael A Eckhaus; David J Venzon; Ronald E Gress; Christopher G Kanakry
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 19.456

8.  Retroviral transduction of peptide stimulated t cells can generate dual t cell receptor-expressing (bifunctional) t cells reactive with two defined antigens.

Authors:  Alexander Langerman; Glenda G Callender; Michael I Nishimura
Journal:  J Transl Med       Date:  2004-12-08       Impact factor: 5.531

Review 9.  Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding.

Authors:  Natalia S Nunes; Christopher G Kanakry
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

Review 10.  Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.

Authors:  Susanne H C Baumeister; Benedetta Rambaldi; Roman M Shapiro; Rizwan Romee
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.